Shanghai Shen Lian Biomedical Corp Total Liabilities
Shanghai Shen Lian Biomedical Corp total liabilities. Based on the latest financial reports, Shanghai Shen Lian Biomedical Corp (688098) has total liabilities worth CN¥133.33 Million CNY (≈ $19.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Shanghai Shen Lian Biomedical Corp's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shanghai Shen Lian Biomedical Corp (2013–2025)
Total liabilities of Shanghai Shen Lian Biomedical Corp from 2013 to 2025. This chart illustrates how Shanghai Shen Lian Biomedical Corp's total liabilities have evolved over time, based on quarterly financial data.
Shanghai Shen Lian Biomedical Corp Competitors by Total Liabilities
The table below lists competitors of Shanghai Shen Lian Biomedical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IS:GENIL
|
Turkey | TL7.52 Billion |
|
Bannari Amman Sugars Limited
NSE:BANARISUG
|
India | Rs2.44 Billion |
|
Ningbo Zhongbai Co Ltd
SHG:600857
|
China | CN¥64.61 Million |
|
Allied Circuit Co Ltd
TWO:8155
|
Taiwan | NT$2.83 Billion |
|
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
|
China | CN¥4.18 Billion |
|
Anhui Wantong Technology Co Ltd
SHE:002331
|
China | CN¥1.56 Billion |
|
Petpal Pet Nutrition Technology Co Ltd
SHE:300673
|
China | CN¥987.01 Million |
|
Zhengzhou J and T Hi Tech Co
SHE:300845
|
China | CN¥195.24 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Shanghai Shen Lian Biomedical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shanghai Shen Lian Biomedical Corp balance sheet assets.
Liquidity & Leverage Metrics
Shanghai Shen Lian Biomedical Corp Total Liabilities Ratios Explained
Shanghai Shen Lian Biomedical Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Shen Lian Biomedical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Shen Lian Biomedical Corp (2013–2025)
The table below shows the annual total liabilities of Shanghai Shen Lian Biomedical Corp from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥143.41 Million ≈ $20.99 Million |
+11.61% |
| 2024-12-31 | CN¥128.50 Million ≈ $18.80 Million |
+47.82% |
| 2023-12-31 | CN¥86.93 Million ≈ $12.72 Million |
-19.67% |
| 2022-12-31 | CN¥108.21 Million ≈ $15.83 Million |
-13.76% |
| 2021-12-31 | CN¥125.48 Million ≈ $18.36 Million |
+6.15% |
| 2020-12-31 | CN¥118.20 Million ≈ $17.30 Million |
-28.93% |
| 2019-12-31 | CN¥166.33 Million ≈ $24.34 Million |
-8.20% |
| 2018-12-31 | CN¥181.18 Million ≈ $26.51 Million |
+26.77% |
| 2017-12-31 | CN¥142.92 Million ≈ $20.91 Million |
+0.42% |
| 2016-12-31 | CN¥142.32 Million ≈ $20.83 Million |
-17.69% |
| 2015-12-31 | CN¥172.90 Million ≈ $25.30 Million |
-39.82% |
| 2014-12-31 | CN¥287.32 Million ≈ $42.04 Million |
+40.88% |
| 2013-12-31 | CN¥203.94 Million ≈ $29.84 Million |
-- |
About Shanghai Shen Lian Biomedical Corp
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.